Navigation Links
New Research: Nationwide Report Shows Prescribed Drugs Not Detected in More Than One-Third of Pain Patient Samples
Date:6/20/2013

BALTIMORE, June 20, 2013 /PRNewswire/ -- A new report issued today by Ameritox, the nation's leader in pain medication monitoring, revealed that more than one-third (35.9 percent) of samples collected from patients prescribed opioid medications for chronic pain management last year did not contain their prescribed drug, an increase from the 31 percent found in similar research released in October 2010.

In both the 2010 and 2012 surveys, Ameritox analyzed samples from more than half a million patients collected over a twelve-month period. The samples used in the 2012 report came from approximately 527,000 individual patients from all 50 states.

"It appears that the epidemic of prescription pain medication abuse is worsening," said Ameritox Chief Executive Scott Walton. "Medication monitoring helps doctors discern medication use, but monitoring alone won't solve the problem. The front line in the battle against pain medication abuse and addiction is at the clinical level, and we will be vigilant in equipping doctors with the best possible tools to face this challenge head on."

Kathryn Bronstein, Vice President of Medical Affairs at Ameritox, said that the data underscores the importance of medication monitoring. "There is no doubt that pain medication is critical to the care millions of individuals receive across the country. For many people living with chronic pain, these medicines are the only option for relief of their symptoms. But they must be used correctly to be used safely."

This most recent survey showed that the District of Columbia (47.8 percent), Michigan (45.8 percent), Georgia (45.8 percent), South Carolina (45.7 percent) and Missouri (44.1 percent) had the highest percentage of tests that failed to show the prescribed medication. Minnesota (3 percent), Vermont (14.9 percent) and Maine (16.5 percent) reported the lowest percentages. The complete findings from states with more than 1,000 tests are available at ameritox.com/nationalreport.

In addition to monitoring use of prescribed medications, Ameritox also screens for the presence of other drugs. Nearly one-third (32.3 percent) of the tests detected substances not prescribed by the attending physician, an increase from the 29 percent found in 2010. In both surveys, 11 percent of all samples contained an illicit drug, primarily marijuana. A significant number of tests also found cocaine. Ameritox's research has shown that users of illicit drugs are more likely than non-users to be potentially non-adherent to their prescription drug regimen.

"Consistent, appropriate monitoring for the presence of prescribed, non-prescribed and illicit drugs  not only enables doctors to provide better care, but can also help reduce misuse, abuse and diversion,"  Walton said. "We hope that medication monitoring results can spark a conversation between a doctor and patient.  We believe these conversations will lead to the improved health and wellbeing of the patient."

About Ameritox
Ameritox is the nation's leader in Pain Medication Monitoring SolutionsSM, offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with the information and support they need to enhance and optimize the care of chronic pain patients. Monitoring through prescription drug testing can help physicians make more informed clinical decisions while also helping to reduce the possible risk of misuse, abuse or diversion of powerful medications. Ameritox is headquartered in Baltimore, Md. with laboratory facilities in Midland, Texas and Greensboro, N.C. Ameritox can be found online at http://www.ameritox.com, on Twitter @Ameritox, on Facebook at facebook.com/ameritox, and on YouTube at youtube.com/ameritox.

© 2013 Ameritox Ltd. All rights reserved. Ameritox, Ameritox-Medication Monitoring Solutions, Rx Guardian, Rx Guardian INSIGHT and Rx Guardian CD are trademarks of Ameritox. Other trademarks are the property of their owners.


'/>"/>
SOURCE Ameritox
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medical Devices Research: Country Reports on Market Profile, Competitive Environment and more at RnRMarketResearch.com
2. Zydus Pharmaceuticals USA Inc. Issues Voluntary Nationwide Recall of Warfarin 2 mg Tablets, Lot MM5767, Expiration Date June 2014, Due to Oversized Tablets
3. Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy
4. Green Valley Drugs Announces Voluntary Nationwide Recall Of All Lots Of All Sterile Products Compounded, Repackaged, And Distributed By Green Valley Drugs Due To Quality Control Concerns
5. CVS Caremark Charitable Trust Supports Non-profits Nationwide with $2.6 Million in Funding
6. Quest Diagnostics to Provide Nationwide Access to Nateras New Non-Invasive Prenatal Test
7. Swisse Wellness, Australias #1 Multivitamin Brand, Arrives at Walgreens Stores Nationwide
8. MDH Radiology Selects Sectra for Nationwide Telemammography Solution
9. Qualitest Issues Voluntary, Nationwide Recall of 101 Lots of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets
10. Ranbaxy Issues Voluntary Nationwide Recall of 41 lots of Atorvastatin Calcium Tablets 10 mg, 20 mg and 40 mg Due to Potential Presence of Foreign Substance
11. Zi Xiu Tang Success, LLC Issues Voluntary Nationwide Recall of Classic Zi Xiu Tang Bee Pollen Capsules and Ultimate Formula Capsules due to Undeclared Sibutramine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... -- Memorial Hermann Health System has teamed up with Houston ... a one-of-a-kind experience to pediatric patients at Children,s ... 360-degree video and Google Cardboard, Howard was able to ... the patients and their families an unexpected, and energetically ... video . Memorial Hermann IRONMAN Sports ...
(Date:2/12/2016)... 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ... Company will ring the Nasdaq Closing Bell at the ... at 4:00 p.m. ET on Tuesday, February ... Adrian Adams , will perform the honorary ... 4:00 p.m. ET.  A live webcast will be available ...
(Date:2/12/2016)... 12, 2016 --> ... Chronic Inflammation Global Clinical Trials Review, H2, 2015 ... global clinical trials landscape along with top level ... Country (G7 & E7), Trial Status, Trial Phase, ... top companies involved and enlists all trials (Trial ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... With FCPX Overlay Embers from Pixel Film Studios users can now apply ... user can select from up to 40 effect overlays. With FCPX Overlay Embers users ... value, contrast, glow, and more all within a click of a mouse. , ...
(Date:2/13/2016)... ... , ... When an Au Pair comes all the way around the world to ... and they are often worried things won’t go well. More often than not, however, they ... Pair of the Year winner’s all commented how their Au Pairs have become a part ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mystic Buddha Publishing House presents Valentine’s ... Buddha, the biography of Rama - Dr. Frederick Lenz. , According to ... of a Buddhist teacher for teaching and helping others. Valentine’s Day celebrates love ...
(Date:2/12/2016)... ... ... , Back to the Future , Feb. 25, 2016 — 11:00 a.m. – 12:30 p.m. ... learn from history are doomed to repeat it.” , An analysis of CDRH’s enforcement actions ... takes time. , Take a close look at the warning letters the agency sent ...
(Date:2/12/2016)... ... ... Coco Libre, the maker of coconut water beverages with a purpose, is ... Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, a ... suite, held this year at the W Hollywood Hotel, has become a pre-show “must” ...
Breaking Medicine News(10 mins):